Wynn Thai

Wynn Thai

Senior Director, Business Development, Drug Product

Business Development
About

Wynn has over 20 years of industry experience from the lab to business development roles in contract manufacturing. With a diverse background in both Drug Substance and Drug Product across modalities of Small Molecules, Peptides and Biologics. Covering projects in development phases from Clinical through to Commercial and Generics segments.

Being flexible and approachable, he brings a passionate understanding of client needs and how best to work together towards success. As he represents Quotient Sciences Drug Product services for Western territory of North America.”

Quotient Sciences Logo
News & Announcements

Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment

Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Artificial Intelligence Andy Lewis on AI‑Enabled Formulation Design and Faster Speed to Clinic By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Early Drug Development, Artificial Intelligence AI's Role in Fast-tracking Early Drug Development; Our ground breaking alliance with Intrepid Labs By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Artificial Intelligence Building Trust in AI‑Enabled Formulation: Insights from Quotient Sciences and Intrepid Labs By: Andy Lewis
Read More